Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies

BACKGROUND: Gastric cancer (GC) is confronted with limited options for precision medicine. Human epidermal growth factor receptor 2 (HER2) is the principal druggable target of GC, yet proper biomarkers for response/resistance prediction remain unveiled. METHODS: From 40 GC patients received HER2‐tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cheng, Chen, Zuhua, Chong, Xiaoyi, Chen, Yang, Wang, Zhenghang, Yu, Ruoying, Sun, Tingting, Chen, Xiaoxi, Shao, Yang, Zhang, Xiaotian, Gao, Jing, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737756/
https://www.ncbi.nlm.nih.gov/pubmed/33377634
http://dx.doi.org/10.1002/ctm2.254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737756/
https://www.ncbi.nlm.nih.gov/pubmed/33377634
http://dx.doi.org/10.1002/ctm2.254

Ejemplares similares